On Wednesday, September 30, 2026, the African Healthcare Association hosted an impactful virtual session titled “Truth, Treatment & Triumph in Sickle Cell Disease,” led by Dr. Enam Sefakor Bankas, a Ghanaian Hematologist at Korle‑Bu Teaching Hospital and one of Africa’s influential voices in Sickle Cell Disease advocacy.
Our community gathered from across the continent and the diaspora for a deeply informative discussion on SCD: its science, its lived reality, and the path toward equitable, modern care for all patients.
Dr. Bankas is a clinician, researcher, and internationally recognized SCD advocate. She is the Founder of Sickle Life, a nonprofit advancing SCD awareness and patient support, and Co‑Founder of Heale, a community‑centered initiative focused on psychosocial care for people with benign hematological conditions. Her work spans clinical hematology, laboratory medicine, research, public speaking, and she currently serves as a Sub‑Investigator on the PIVOT Clinical Trial, advancing SCD research in Africa.
Session Highlights
Understanding Sickle Cell Disease
Dr. Bankas began with a clear overview of SCD as a genetic disorder affecting red blood cells, caused by mutations in the β‑globin gene. She explained inheritance patterns (HbSS, HbSC, HbAS) and emphasized the importance of early diagnosis.
Over 300,000 babies are born with SCD annually. 75% of cases occur in Africa. In Ghana, 15–30% of the population carries the sickle trait.
Pathophysiology & Clinical Features
We learned how sickled cells obstruct blood flow, causing pain, organ damage, anemia, and life‑threatening infections. Symptoms often begin around 6 months of age.
SCD is a multisystem condition with both acute and chronic complications: physical, psychological, and social.
Early Diagnosis & Comprehensive Care
Dr. Bankas outlined the full spectrum of diagnostic tools providing us her great perspective on pros and cons of currently available rapid tests, Hb electrophoresis, genetic tests and HPLC that are commonly used in prenatal and newborn screening as well as community‑based screening. She also provided an overview of what comprehensive care looks like, including both disease-modifying therapies as well as curative approaches in development. Dr. Bankas emphasized that while science is advancing rapidly, access remains unequal, especially in Africa.
Dr. Bankas closed with a powerful message: The goal of modern SCD care is not just survival, it is the ability to live fully! Triumph for patients with SCD means attending schools, building a career, having relationships and families, participating in society, maintaining physical and mental wellbeing, and being treated with dignity.
Healthcare providers must listen, believe patients, avoid judgmental language, and treat the whole person, not just the crisis.
Our audience brought thoughtful questions and reflections around AI tools that can be leveraged for patient education, diagnostics, and health‑system strengthening, highlighting the growing role of digital tools in African healthcare.
This conversation reflects AHA’s commitment to education, equity, and community‑centered healthcare across Africa. We extend our deepest appreciation to Dr. Enam Bankas for her expertise and advocacy.
Stay connected for upcoming sessions and resources at: www.AfricanHealthcareAssociation.com